PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.02%
Positive revenue growth while QCOM is negative. John Neff might see a notable competitive edge here.
-3.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-3.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.06%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.75%
Negative net income growth while QCOM stands at 5.81%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-0.53%
Negative EPS growth while QCOM is at 5.88%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1.07%
Negative diluted EPS growth while QCOM is at 5.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.09%
Dividend growth under 50% of QCOM's 7.17%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
38.46%
OCF growth under 50% of QCOM's 82.36%. Michael Burry might suspect questionable revenue recognition or rising costs.
1040.43%
FCF growth above 1.5x QCOM's 134.16%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.63%
10Y revenue/share CAGR at 50-75% of QCOM's 109.67%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
13.51%
5Y revenue/share CAGR under 50% of QCOM's 100.08%. Michael Burry would suspect a significant competitive gap or product weakness.
19.91%
3Y revenue/share CAGR under 50% of QCOM's 74.57%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
103.13%
10Y OCF/share CAGR in line with QCOM's 98.14%. Walter Schloss would see both as similarly efficient over the decade.
-1.85%
Negative 5Y OCF/share CAGR while QCOM is at 71.55%. Joel Greenblatt would question the firm’s operational model or cost structure.
35.56%
3Y OCF/share CAGR at 75-90% of QCOM's 43.46%. Bill Ackman would press for improvements in margin or overhead to catch up.
227.96%
Net income/share CAGR above 1.5x QCOM's 76.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
16.17%
Below 50% of QCOM's 96.06%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
27.56%
Below 50% of QCOM's 115.67%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
81.65%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
68.77%
5Y equity/share CAGR above 1.5x QCOM's 18.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
101.75%
Below 50% of QCOM's 531.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
341.28%
10Y dividend/share CAGR above 1.5x QCOM's 129.00%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
99.61%
5Y dividend/share CAGR above 1.5x QCOM's 29.94%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
37.84%
3Y dividend/share CAGR above 1.5x QCOM's 23.14%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
1.02%
AR growth is negative/stable vs. QCOM's 4.31%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.80%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.26%
Asset growth above 1.5x QCOM's 1.32%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.34%
75-90% of QCOM's 5.03%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.03%
We have some new debt while QCOM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-1.26%
Our R&D shrinks while QCOM invests at 0.54%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.95%
We cut SG&A while QCOM invests at 0.65%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.